|
|
Reproductive Toxicology Official Journal of the European Teratology Society Aims and Scope: Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.
Visit our Website at: www.elsevier.com/locate/reprotox
All aspects of reproduction will be within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.
Indexed in: Bibliography of Reproduction, BIOSIS Database, Elsevier BIOBASE/Current Awareness in Biological Sciences1, Current Contents/Life Sciences, Reproductive Research, Science Citation Index1, SciSearch1, Biomedical databases Advertising information: Advertising orders and enquiries can be sent to: USA, Canada and South America: Mr Tino DeCarlo, The Advertising Department, Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710, USA; phone: (+1) (212) 633 3815; fax: (+1) (212) 633 3820; e-mail:
[email protected]. Europe and ROW: Katrina Barton, Print Operations Co-ordinator, Elsevier, 84 Theobalds Road, London, WC1X 8RR; Tel.: +44 (0) 20 7611 4117; Fax: +44 (0) 20 7611 4463; mail to:
[email protected]
Editor-in-Chief Dr. Thomas B. Knudsen, Ph.D., University of Louisville, Birth Defects Center, Room 301, 501 South Preston Street, Louisville, KY 40202, U.S.A. Tel.: (+1) (502) 852 7507 or -4128; Fax: (+1) (502) 852 4702; E-mail:
[email protected]
Manuscripts should be submitted to: Reproductive Toxicology, Editorial Office, Dr. Thomas B. Knudsen, Ph.D., University of Louisville, Birth Defects Center, Room 301, 501 South Preston Street, Louisville, KY 40202, U.S.A.; Tel.: (+1) (502) 852 7507 or – 4128; Fax: (+1) (502) 852 4702; E-mail:
[email protected]
Associate Editors Dr. Nigel Brown, Medical Research Council laboratories, EETU, St. George’s Medical School, University of London, Cranmer Terrace, London, SW17 ORE, U.K.
Language Editing: International Science Editing and Asia Science Editing can provide English language and copyediting services to authors who want to publish in scientific, technical and medical journals and need assistance before they submit their article or before it is accepted for publication. Authors can contact these services directly: International Science Editing (http://www.internationalscienceediting.com) and Asia Science Editing (http://www.asiascienceediting.com) or, for more information about language editing services, please contact
[email protected] who will be happy to deal with any questions. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please refer to our terms & conditions (http://authors. elsevier.com/terms_and_conditions.html).
Dr. W.S. Webster, Department of Anatomy, University of Sydney, New South Wales 2006, Australia Founding Editor Dr. Anthony R. Scialli, Principal Scientist, Sciences International, Inc., 1800 Diagonal Road, Suite 500, Alexandria, VA 22314–2808, U.S.A. E-mail:
[email protected] Barbara Abbott (U.S.A.) James Andrews (U.S.A.) Elisabetta Baldi (Italy) John Bannigan (Ireland) Sidney L. Beck (U.S.A.) Judy Buelke-Sam (U.S.A.) Jochen Buschmann (Germany) Edward W. Carney (U.S.A.) Robert L. Clark (U.S.A.) Maurizio Clementi (Italy) Audrey Cummings (U.S.A.) M. Elmazar (Egypt) Giavini Erminio (Italy) Warren G. Foster (Canada)
Editorial Board Barbara F. Hales (Canada) Kok Wah Hew (U.S.A.) John F. Jarrell (Canada) Debra Kennedy (Australia) Carole A. Kimmel (U.S.A.) Gary R. Klinefelter (U.S.A.) Devendra M. Kochhar (U.S.A.) Christopher Lau (U.S.A.) Alberto Mantovani (Italy) Eve Mylchreest (U.S.A.) Heinz Nau (Germany) Asher Ornoy (Israel) Francisco Jose Roma Paumgartten (Brasil)
No responsibility is assumed by the Publisher or the Society for statements made in the Journal or consequences arising from such statements, and no responsibility is assumed by the Publisher or the Society for any injury and/or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, dosages or ideas contained in the material herein. Because of rapid advances in the medical sciences, independent verification should be made of diagnosis and drug dosages, and of medical equipment and medical supplies. The Publisher recommends that consultation also be made with the Physicians’ Desk Reference (PDR) and drug package literature.
Aldert Piersma (The Netherlands) Jacqui Piner (U.K.) Janine E. Polifka (U.S.A.) William F. Rayburn (U.S.A.) Helen Ritchie (Australia) Joe C. Rutledge (U.S.A.) Anne Marie Saillenfait (France) Makoto Shubatini (Japan) William Slikker (U.S.A.) William J. Swartz (U.S.A.) Vladimir Toder (Israel) Calvin Willhite (U.S.A.) Michiko Yamanaka (Japan) Barry R. Zirkin (U.S.A.)
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. # 2005 Elsevier Inc. All rights reserved. USA mailing notice: Reproductive Toxicology (ISSN 0890-6238) is published bi-monthly and monthly by Elsevier Inc. (P.O. Box 211, 1000 AE Amsterdam, The Netherlands). Annual subscription price in the USA US$ 1,327 (valid in North, Central and South America), including air speed delivery. Application to mail at periodical postage rate is pending at Jamaica, NY 11431. USA POSTMASTER: Send address changes to Reproductive Toxicology, Elsevier, 6277 Sea Harbour Drive, Orlando, FL 32887-4800. AIRFREIGHT AND MAILING in the USA by Publications Expediting Inc., 200 Meacham Avenue, Elmont, NY 11003.
Publication information: Reproductive Toxicology (ISSN 0890-6238). For 2005, volumes 19–20 are scheduled for publication. Subscription prices are available upon request from the Publisher or from the Regional Sales Office nearest you or from this journal’s website (http://www.elsevier.com/locate/ reprotox). Further information is available on this journal and other Elsevier products through Elsevier’s website: (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, all delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch.
Author enquiries: For enquiries relating to the submission of articles (including electronic submission where available) please visit Elsevier’s Author Gateway at http://authors.elsevier.com. The Author Gateway also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article’s status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more.
Orders, claims, and journal enquiries: please contact the Customer Service Department at the Regional Sales Office nearest you: Orlando: Elsevier, Customer Service Department, 6277 Sea Harbor Drive, Orlando, FL 32887-4800, USA; phone: (877) 8397126 or (800) 6542452 [toll free numbers for US customers]; (+1) (407) 3454020 or (+1) (407) 3454000 [customers outside US]; fax: (+1) (407) 3631354 or (+1) (407) 3639661; e-mail:
[email protected] or
[email protected]
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication.
Amsterdam: Elsevier, Customer Service Department, PO Box 211, 1000 AE Amsterdam, The Netherlands; phone: (+31) (20) 4853757; fax: (+31) (20) 4853432; e-mail:
[email protected] Tokyo: Elsevier, Customer Service Department, 4F Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; phone: (+81) (3) 5561 5037; fax: (+81) (3) 5561 5047; e-mail:
[email protected]
Reproductive Toxicology has no page charges
Singapore: Elsevier, Customer Service Department, 3 Killiney Road, #08-01 Winsland House I, Singapore 239519; phone: (+65) 63490222; fax: (+65) 67331510; e-mail:
[email protected]
|
|